Skip to main content

Table 1 Baseline characteristics of the CHD case and control subjects

From: Associations of the uric acid related genetic variants in SLC2A9 and ABCG2 loci with coronary heart disease risk

Variables

CHD cases (n = 1,146)

Control subjects (n = 1,146)

P value

Age (years)

60.0 ± 10.3

60.5 ± 11.3

0.229

Gender (male/female)

891/255 (77.7/22.3)

901/245 (78.6/21.4)

0.613

BMI (kg/m2)

24.4 ± 3.3

23.7 ± 3.1

<0.01

Smoking, no/yes, (%)

774/369 (66.7/32.3)

686/460 (59.9/40.1)

<0.01

Drinking, no/yes, (%)

822/317 (72.2/27.8)

776/365 (68.0/32.0)

<0.01

Systolic blood pressure (mmHg)

136.0 ± 25.3

133.6 ± 29.0

0.034

Diastolic blood pressure (mmHg)

82.9 ± 15.2

82.0 ± 11.3

0.110

Fasting blood glucose (mmol/L)

6.2 ± 3.0

5.6 ± 2.2

<0.01

Total cholesterol (mmol/L)

4.4 ± 1.1

4.7 ± 0.9

<0.01

Triglyceride (mmol/L)

1.7 ± 1.4

1.6 ± 1.3

0.283

HDL cholesterol (mmol/L)

1.2 ± 0.7

1.1 ± 0.4

<0.01

LDL cholesterol (mmol/L)

2.6 ± 0.9

2.7 ± 0.8

<0.01

Past history

   

  Diabetes, no/yes, (%)

824/314 (72.4/27.6)

1080/65 (94.3/5.7)

<0. 01

  Hypertension, no/yes, (%)

351/790 (30.8/69.2)

784/361 (68.5/31.5)

<0. 01

Family history of CHD, no/yes, (%)

947/158 (85.7/14.3)

1133/10 (99.1/0.9)

<0.01

  1. Values are mean ± SD, n (%) or as indicated. CHD: coronary heart disease; BMI: body mass index; HDL: high density lipoprotein; LDL: low density lipoprotein.